Pacira BioSciences Inc. (PCRX)
Pacira BioSciences Max Pain By Strike
PCRX trades at $25.19, 12.0% above the near-term max pain of $22.5 expiring Sep 19, 2025 (30 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$25), signaling increased put positioning or downside protection. Key magnetic zone at 25 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Pacira BioSciences Max Pain By Expiry
Max pain for PCRX shows a downward trend from 25 to 2.5, indicating bearish sentiment or hedging activity. The 126% spread signals divergent expectations across timeframes. Most levels below 25.19 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Sep 19, 2025 | 22.5 | -2.69 (-10.68%) |
Oct 17, 2025 | 12.5 | -12.69 (-50.38%) |
Nov 21, 2025 | 25 | -0.19 (-0.75%) |
Dec 19, 2025 | 25 | -0.19 (-0.75%) |
Jan 16, 2026 | 17.5 | -7.69 (-30.53%) |
Feb 20, 2026 | 20 | -5.19 (-20.60%) |
Jan 15, 2027 | 2.5 | -22.69 (-90.08%) |